Study S001625

Advantages of Liraglutide Mediated Through Its Effect on Clock Gene mRNA Expression

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02783196
Acronym: LIR-CG
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: TRIPLE
Status: UNKNOWN
Enrollment: 14
Start: 2016-07
Primary completion: 2016-12
Lead sponsor: Tel Aviv University
Conditions: Type 2 Diabetes
Interventions: DRUG:Liraglutide; DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Clock Gene expression [Up to 95 days]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.